We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
-6.43%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$12.9B
AUM Growth
-$560M
Cap. Flow
+$558M
Cap. Flow %
4.31%
Top 10 Hldgs %
51.42%
Holding
672
New
56
Increased
213
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
MCO icon
Moody's
MCO
+$25.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23.8M
3
SOPH icon
SOPHiA GENETICS
SOPH
+$23.6M
4
AMZN icon
Amazon
AMZN
+$23.1M
5
ZTS icon
Zoetis
ZTS
+$17M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$307M
2
LPX icon
Louisiana-Pacific
LPX
+$25.1M
3
TSLA icon
Tesla
TSLA
+$21.4M
4
NVCR icon
NovoCure
NVCR
+$18.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$14.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.18%
2 Healthcare 17.7%
3 Communication Services 10.57%
4 Technology 9.47%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSN icon
326
Tyson Foods
TSN
$19.6B
$2.08M 0.02%
23,265
-1,439
-6% -$131K
CLF icon
327
Cleveland-Cliffs
CLF
$6.99B
$2.02M 0.02%
62,775
+20,602
+49% +$470K
BWA icon
328
BorgWarner
BWA
$14B
$2.01M 0.02%
58,649
+955
+2% +$35.7K
UA icon
329
Under Armour Class C
UA
$2.2B
$2.01M 0.02%
+129,003
New +$2.02M
EPOL icon
330
iShares MSCI Poland ETF
EPOL
$825M
$2M 0.02%
105,000
– –
ASND icon
331
Ascendis Pharma A/S
ASND
$16.8B
$1.98M 0.02%
16,825
+7,846
+87% +$909K
QCOM icon
332
Qualcomm
QCOM
$171B
$1.97M 0.02%
12,898
+5,773
+81% +$968K
SNA icon
333
Snap-on
SNA
$21.1B
$1.97M 0.02%
9,581
+502
+6% +$106K
Z icon
334
Zillow
Z
$7.48B
$1.96M 0.02%
39,811
+4,730
+13% +$254K
BHVN
335
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.95M 0.02%
16,400
+636
+4% +$79.3K
ARVN icon
336
Arvinas
ARVN
$580M
$1.94M 0.02%
28,818
+1,115
+4% +$76K
LH icon
337
Labcorp
LH
$26.2B
$1.94M 0.02%
8,561
+503
+6% +$118K
PVH icon
338
PVH
PVH
$3.76B
$1.93M 0.01%
25,232
+3,733
+17% +$346K
LKQ icon
339
LKQ Corp
LKQ
$6.25B
$1.93M 0.01%
42,410
+4,435
+12% +$227K
ALNY icon
340
Alnylam Pharmaceuticals
ALNY
$30B
$1.92M 0.01%
11,774
-4,707
-29% -$717K
AIZ icon
341
Assurant
AIZ
$13.9B
$1.92M 0.01%
10,570
+2,150
+26% +$352K
IBM icon
342
IBM
IBM
$222B
$1.91M 0.01%
14,718
+50
+0.3% +$6.52K
MASI
343
DELISTED
Masimo
MASI
$1.91M 0.01%
13,086
+3,054
+30% +$586K
FATE icon
344
Fate Therapeutics
FATE
$317M
$1.89M 0.01%
48,855
+1,893
+4% +$73.3K
IPG
345
DELISTED
Interpublic Group of Companies
IPG
$1.89M 0.01%
53,273
-3,296
-6% -$119K
BEN icon
346
Franklin Resources
BEN
$17.1B
$1.88M 0.01%
67,349
+8,454
+14% +$258K
FOXA icon
347
Fox Class A
FOXA
$26.5B
$1.88M 0.01%
47,662
-2,800
-6% -$114K
LBTYA icon
348
Liberty Global Class A
LBTYA
$3.55B
$1.86M 0.01%
72,875
+5,464
+8% +$145K
VWO icon
349
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$1.85M 0.01%
40,097
-21,472
-35% -$1.03M
DIA icon
350
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$1.83M 0.01%
5,280
– –
12 13
14
15 16

Similar funds

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Banque Pictet & Cie's Q1 2022 Portfolio in Review

As of Q1 2022, Banque Pictet & Cie held 672 positions worth $12.9B, down 4.1% from $13.5B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Banque Pictet & Cie deployed $558M of net new capital in Q1 2022, opening 56 new positions and adding to 213 existing holdings. Its largest new stake was SOPHiA GENETICS: 2,096,420 shares worth $16.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $307M trimmed.

  • Banque Pictet & Cie's largest Q1 2022 buy was SOPHiA GENETICS: 2,096,420 shares worth $16.2M.
  • Banque Pictet & Cie added most to Moody's in Q1 2022, an estimated $25.9M increase.
  • Banque Pictet & Cie's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $307M.
  • Banque Pictet & Cie fully exited Louisiana-Pacific in Q1 2022, selling an estimated $25.1M.
  • Banque Pictet & Cie's ten largest holdings make up 51% of its $12.9B portfolio in Q1 2022.
  • Banque Pictet & Cie opened 56 new positions and closed 50 in Q1 2022.
  • Banque Pictet & Cie's portfolio value fell 4.1% quarter-over-quarter to $12.9B.

Based on Banque Pictet & Cie's 13F filing for Q1 2022, filed 4 May 2022.